AI-generated summary
The authors reviewed charts of children treated with a 308-nm laser for vitiligo, recording initial repigmentation in 2016 and retained pigmentation in 2021. They report initial repigmentation of 86.7% on the face, 80% on the body and 61.7% on the extremities, with retention of 80% for facial lesions, 40% for body and 20% for extremity lesions. The average follow-up was 3.38 years.
- Who or what was studied
- Children with vitiligo treated with a 308-nm laser
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract describes a retrospective chart review without a control group, and the authors call for broader evaluation of the site-scoring approach.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Digital object identifier. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.